FCN2 and ovarian neoplasm: We report for the first time the expression of the FCN2 and FCN3 genes in the ovary, their polymorphisms, and their serum concentrations in patients with ovarian tumours (both malignant and benign) as well as women operated on for reasons unconnected with ovarian tumours.